Edition:
United Kingdom

Zynerba Pharmaceuticals Inc (ZYNE.OQ)

ZYNE.OQ on NASDAQ Stock Exchange Global Market

8.09USD
18 Apr 2019
Change (% chg)

$-0.14 (-1.70%)
Prev Close
$8.23
Open
$8.12
Day's High
$8.19
Day's Low
$7.60
Volume
197,334
Avg. Vol
239,632
52-wk High
$12.50
52-wk Low
$2.76

About

Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in developing and commercializing transdermal synthetic cannabinoid treatments for patients with high unmet needs. Its development pipeline includes two product candidates: ZYN002 and ZYN001. ZYN002 is a synthetic cannabidiol (CBD), which... (more)

Overall

Beta: --
Market Cap(Mil.): $128.07
Shares Outstanding(Mil.): 13.26
Dividend: --
Yield (%): --

Financials

  ZYNE.OQ Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -2.62 -- --
ROI: -55.80 8.91 13.83
ROE: -55.80 10.06 15.25

Earnings vs. Estimates